000			01674nam a22001937a 4500
005			20231025152013.0
008			231025b ph ||||| |||| 00| 0 eng d
022			_a0279-3695
040			_cOCT
100			_aMumba, Mercy Ngosa
240			_aJournal of Psychological Nursing and mental health services _hMarch 2023
245			_aAre we witnessing a new wave of substance use disorders? / _cMercy Ngosa Mumba and Lori L. Davis
260			_aThorofare, NJ _bSlack Inc. _c2023
300			_avol.61 (3): pages 13-18
500			_aAbstract: Stimulant use disorders are emerging as a serious global threat to health. Although research, clinical, and policy efforts have largely concentrated on opioid use disorders over the past decade, exponential rises in prevalence and overdose deaths attributable to stimulant use disorders warrant renewed attention. To date, no approved medications are available to treat stimulant use use disorders; however, behavioral interventions have been effective and should be proactively promoted. Similarly, complementary and integrative therapies and harm reduction services have emerging evidence for effectiveness in treating these conditions. Research, practice, and policy interventions should address stigma for medications for stimulant use disorders when available, vaccine hesitancy if vaccines are approved and safe, environmental surveillance to reduce population exposure to toxic effects of methamphetamines, and educational interventions for health providers to increase competency to reduce the long term effects on various body systems.
653			_aStimulant use disorders
700			_aDavis, Loris
942			_2ddc _cCR _n0
999			_c9274 _d9274